Literature DB >> 4465768

Trade names or approved names. Part III. Special cases. Combination products.

B W Cromie.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4465768      PMCID: PMC2495495          DOI: 10.1136/pgmj.50.580.103

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  11 in total

1.  Prescribing and the british national formulary.

Authors:  O L Wade; G D McDevitt
Journal:  Br Med J       Date:  1966-09-10

2.  Evaluation of iron supplements in prevention of iron-deficiency anaemia.

Authors:  P C Elwood; W E Waters; W J Greene
Journal:  Lancet       Date:  1970-07-25       Impact factor: 79.321

3.  Pharmacokinetic drug interactions.

Authors:  L F Prescott
Journal:  Lancet       Date:  1969-12-06       Impact factor: 79.321

4.  A hopefully biased pilot survey of physicians' knowledge of the content of drug combinations.

Authors:  P Biron
Journal:  Can Med Assoc J       Date:  1973-07-07       Impact factor: 8.262

5.  Drug combinations.

Authors:  B W Cromie
Journal:  Curr Med Res Opin       Date:  1972       Impact factor: 2.580

6.  Mechanisms of drug interaction.

Authors:  H M Solomon; M J Barakat; C J Ashley
Journal:  JAMA       Date:  1971-06-21       Impact factor: 56.272

7.  To be taken as directed.

Authors:  M S Gatley
Journal:  J R Coll Gen Pract       Date:  1968-07

8.  Prescribed drugs ... errors during self-administration.

Authors:  J C Clinite; H F Kabat
Journal:  J Am Pharm Assoc       Date:  1969-09       Impact factor: 2.217

9.  The effect of instruction and labeling on the number of medication errors made by patients at home.

Authors:  B Malahy
Journal:  Am J Hosp Pharm       Date:  1966-06

10.  Drug defaulting in a general practice.

Authors:  A M Porter
Journal:  Br Med J       Date:  1969-01-25
View more
  1 in total

1.  Pharmacological appraisal of fixed-dose combination medicines: discussion paper.

Authors:  E S Snell
Journal:  J R Soc Med       Date:  1982-06       Impact factor: 18.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.